Cargando…

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022

Detalles Bibliográficos
Autores principales:	Chung, Jessie R., Kim, Sara S., Kondor, Rebecca J., Smith, Catherine, Budd, Alicia P., Tartof, Sara Y., Florea, Ana, Talbot, H. Keipp, Grijalva, Carlos G., Wernli, Karen J., Phillips, C. Hallie, Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Reis, Michael, Geffel, Krissy Moehling, Nowalk, Mary Patricia, DaSilva, Juliana, Keong, Lisa M., Stark, Thomas J., Barnes, John R., Wentworth, David E., Brammer, Lynnette, Burns, Erin, Fry, Alicia M., Patel, Manish M., Flannery, Brendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911998/ https://www.ncbi.nlm.nih.gov/pubmed/35271561 http://dx.doi.org/10.15585/mmwr.mm7110a1

Ejemplares similares

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
por: Kim, Sara S., et al.
Publicado: (2022)

Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022
por: Ahmed, Faruque, et al.
Publicado: (2023)

1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
por: McLean, Callie, et al.
Publicado: (2023)

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
por: Tartof, Sara Y., et al.
Publicado: (2023)

Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021
por: Chung, Jessie R., et al.
Publicado: (2022)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018
por: Ladva, Chandresh N, et al.
Publicado: (2019)

Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
por: Sumner, Kelsey M., et al.
Publicado: (2023)

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018
por: Kim, Sara S, et al.
Publicado: (2019)

Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March–November 2020
por: Shafer, Livvy, et al.
Publicado: (2023)

Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems
por: Brammer, Lynnette, et al.
Publicado: (2009)

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
por: Spencer, Sarah, et al.
Publicado: (2021)

Effect of mild COVID-19 on health-related quality of life
por: Nowalk, Mary Patricia, et al.
Publicado: (2023)

LB12. A Randomized Controlled Trial of Antibody Response to 2018–2019 Cell-based vs. Egg-based Quadrivalent Inactivated Influenza Vaccine in Children
por: Moehling, Krissy, et al.
Publicado: (2019)

Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2
por: Chung, Jessie R, et al.
Publicado: (2020)

650 Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network
por: Clippard, Jessie, et al.
Publicado: (2014)

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16
por: Appiah, Grace D., et al.
Publicado: (2018)

Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
por: Doyle, Joshua D., et al.
Publicado: (2019)

535 Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network
por: Flannery, Brendan, et al.
Publicado: (2014)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
por: Havers, Fiona P., et al.
Publicado: (2018)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016
por: Havers, Fiona P, et al.
Publicado: (2017)

99. Immune Responses to Influenza Vaccines in Children and Young Adults
por: Williams, Katherine V, et al.
Publicado: (2021)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018
por: Chung, Jessie R, et al.
Publicado: (2019)

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients
por: Zimmerman, Richard K., et al.
Publicado: (2016)

1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
por: Kramer, Kailey Hughes, et al.
Publicado: (2023)

1125 Viral Infections In Outpatients With Medically Attended Acute Respiratory Illness During the 2012-13 Influenza Season
por: Zimmerman, Richard K., et al.
Publicado: (2014)

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness
por: Flannery, Brendan, et al.
Publicado: (2020)

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016
por: Alyanak, Elif, et al.
Publicado: (2018)

Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016
por: Balasubramani, Goundappa K., et al.
Publicado: (2020)

Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020
por: Olsen, Sonja J., et al.
Publicado: (2020)

Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season
por: Zimmerman, Richard K, et al.
Publicado: (2014)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection
por: Bi, Qifang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rc45vj2ecortk03f1r5k35p91i